Non-Vitamin K Antagonist Oral Anticoagulants in Differentiated Approach to the Use in Cardiological Practice: Literature Review

Non-Vitamin K Antagonist Oral Anticoagulants in Differentiated Approach to the Use in Cardiological Practice: Literature Review

Non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) are important pharmaceuticals for prevention of stroke and systemic embolism in non-valvular atrial fibrillation patients. Vitamin K antagonist warfarin usage is limited due to its pharmacokinetic and pharmacodynamic par...

Full description

Bibliographic Details
Main Authors: Larysa A. Vozniuk, Olga V. Dzekan, Sergii O. Siromakha
Format: Article
Language:English
Published: Professional Edition Eastern Europe 2023-09-01
Series:Український журнал серцево-судинної хірургії
Subjects:
novel oral anticoagulants
rivaroxaban
apixaban
pharmacokinetics
adverse events
antidote
atrial fibrillation
anticoagulants
Online Access:http://cvs.org.ua/index.php/ujcvs/article/view/589

Internet

http://cvs.org.ua/index.php/ujcvs/article/view/589

Similar Items